Learning to Breathe: Optimizing Management of COPD Based on Device Selection

Pharmacy Times, April 2013 Allergy & Asthma, Volume 79, Issue 4

A review of current treatment recommendations for chronic obstructive pulmonary disease with a focus on currently available medication devices.

This activity is supported by an educational grant from Mylan Specialty, LP.

Learning to Breathe: Optimizing Management of COPD Based on Device Selection

Kyle Copeland, PharmD

Clinical Pharmacist SpecialistParkwest Medical CenterKnoxville, Tennessee

Disclosures

The following contributors have no relevant financial relationships with commercial interests to disclose.

Faculty

Kyle Copeland, PharmD

Pharmacy Times Office of Continuing Professional Education Planning Staff

Judy V. Lum, MPA; and Elena Beyzarov, PharmD

Pharmacy Times Editorial Staff

Jennifer Whartenby and David Allikas

PTOCPE uses an anonymous peer reviewer as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.

Educational Objectives

Upon completion of the educational activity, the participant should be able to:

  • Review current treatment recommendations for chronic obstructive pulmonary disease (COPD).
  • Examine currently available medication devices (eg, metered-dose inhalers, dry powder inhalers, nebulizers) in COPD and use of patient-specific factors in device selection.
  • Explore the pharmacist's role in device section and assessing proper device use.
  • Apply the COPD device algorithm to determine the best treatment modality for a given patient.

Target audience: Pharmacists

Type of activity: Knowledge

Release date: April 10, 2013

Expiration date: April 10, 2015

Estimated time to complete activity: 2 hours

Fee: Free

Click here to view this lesson.